ADC Therapeutics SA - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 8731 https://adctherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

HC Wainwright Says This Lymphoma Candidate Has Better Response Rates Than Approved Medications - Jun 13th, 2022 6:43 pm
ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer - Jun 13th, 2022 11:15 am
ADC Therapeutics Announces Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma - Jun 10th, 2022 7:00 am
ADC Therapeutics to Present at the Jefferies Healthcare Conference - Jun 1st, 2022 11:15 am
ADC Therapeutics Announces Abstracts to be Presented at the European Hematology Association 2022 Hybrid Congress - May 12th, 2022 4:15 pm
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates - May 9th, 2022 12:25 pm
ADC Therapeutics Announces CEO Transition - May 9th, 2022 11:00 am
ADC Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates - May 9th, 2022 11:00 am
Should You Buy ADC Therapeutics (ADCT) Ahead of Earnings? - May 6th, 2022 12:08 pm
ADC Therapeutics to Present at the BofA Securities 2022 Healthcare Conference - May 4th, 2022 11:15 am
ADC Therapeutics to Host First Quarter 2022 Financial Results Conference Call on May 9, 2022 - May 3rd, 2022 11:15 am
Shareholders in ADC Therapeutics (NYSE:ADCT) have lost 52%, as stock drops 6.9% this past week - May 2nd, 2022 10:08 am
ADC Therapeutics Receives Permanent J-Code for ZYNLONTA® (J9359) from U.S. Centers for Medicare & Medicaid Services - Apr 4th, 2022 11:15 am
ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2021 - Mar 17th, 2022 12:40 pm
Earnings Beat: ADC Therapeutics SA (NYSE:ADCT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Mar 6th, 2022 1:57 pm
Industry Analysts Just Made A Meaningful Upgrade To Their ADC Therapeutics SA (NYSE:ADCT) Revenue Forecasts - Mar 5th, 2022 11:27 am
Cantor Fitzgerald Cuts ADC Therapeutics Price Target On 'Repositioned Zynlonta Pipeline Strategy' - Mar 4th, 2022 4:45 pm
ADC Therapeutics SA (ADCT) Q4 2021 Earnings Call Transcript - Mar 3rd, 2022 5:31 pm
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates - Mar 3rd, 2022 1:25 pm
ADC Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates - Mar 3rd, 2022 12:00 pm